45 results on '"Hesdorffer, Charles S."'
Search Results
2. Drug-Induced Megaloblastic Anemia
3. Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
4. Increased Oxidative Stress in Humans Under Pathological Conditions Measured by Fluorescent Heme Degradation Product in Red Blood Cells and Whole Blood: 308
5. The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer
6. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4 + T cell responses in cancer patients
7. A Phase I Study of High-dose BCNU, Etoposide and Escalating-dose Thiotepa (BTE) with Hematopoietic Progenitor Cell Support in Adults with Recurrent and High-risk Brain Tumors
8. Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4 + T cells in cancer-free individuals
9. Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses
10. Distinct but overlapping T helper epitopes in the 37–58 region of SSX-2
11. A peripheral circulating compartment of natural naive CD4+ Tregs
12. An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR
13. Multiepitope CD8+ T cell response to an NY-ESO-1 peptide vaccine results in imprecise tumor targeting
14. Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma
15. Retroviral Gene Transfer in Mice: The Use of a Unique Packaging Line Improves Efficiency
16. Distinct energy requirements for human memory CD4 T‐cell homeostatic functions
17. Distinctive immunoregulatory effects of adenosine on T cells of older humans
18. 5-Azacitidine Therapy in Elderly Patients with Acute Myelogenous Leukemia Yields Similar Survival Compared to 3+7 Induction Chemotherapy with Less Transfusional Support, Bacteremias, and Hospital Days.
19. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients
20. CD34+ Selection before Autologous Peripheral Blood Stem Cell Transplantation: Comparison of the Nexell Isolex 300i® and Miltenyi Biotec CliniMACS® Systems.
21. Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals
22. CD4+ T Cell Responses to SSX-4 in Melanoma Patients
23. Identification of an SSX-2 Epitope Presented by Dendritic Cells to Circulating Autologous CD4+ T Cells
24. A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3+ LGL-leukemia
25. Decreased Binding of Peptides-MHC Class I (pMHC) Multimeric Complexes to CD8 Affects Their Binding Avidity for the TCR But Does Not Significantly Impact on pMHC/TCR Dissociation Rate
26. Shifting Gene Expression Profiles During Ex Vivo Culture of Renal Tumor Cells: Implications for Cancer Immunotherapy
27. Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia
28. Membranous Glomerulopathy Associated with Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation
29. The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer
30. CD34+ Cell Dose Requirements for Rapid Engraftment in a Sequential High-Dose Chemotherapy Regimen of Paclitaxel, Melphalan, and Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) with PBPC Support in Metastatic Breast Cancer
31. Naturally Processed Tissue- and Differentiation Stage-Specific Autologous Peptides Bound by HLA Class I and II Molecules of Chronic Myeloid Leukemia Blasts
32. Distinct energy requirements for human memory CD4 T-cell homeostatic functions.
33. Distinctive immunoregulatory effects of adenosine on T cells of older humans.
34. An immunodominant SSX-2--derived epitope recognized by CD4 + T cells in association with HLA-DR.
35. Mitoxantrone, methotrexate, and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer.
36. Aggressive Insulinoma with Bone Metastases
37. Radioisotopic Flow Scanning for Portal Blood Flow and Portal Hypertension
38. CORRESPONDENCE.
39. CD34+Selection before Autologous Peripheral Blood Stem Cell Transplantation: Comparison of the Nexell Isolex 300i® and Miltenyi Biotec CliniMACS® Systems.
40. Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals
41. Drug-Induced Megaloblastic Anemia.
42. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients
43. The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma.
44. SSX antigens as tumor vaccine targets in human sarcoma.
45. Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.